A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants
Clinical trial NCT03550950 · COMPLETED
Trial details
- NCT number
- NCT03550950
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2019-02-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.